Cardiology: 150 CME educational programs available now

Acute Coronary Syndromes

Personalized PCI: Patient-Centered Care in Practice

Feb 3, 2012 13:22 EST

How to put evidence-based care into practice? Drs Skelding and Spertus compare 2 complementary systems used in their respective facilities.

Acute Coronary Syndromes

Surveying the Landscape of Antiplatelet Therapy: Optimizing Outcomes in Atherothrombotic Disease

Jan 20, 2012 13:44 EST

Explore recent advances in ACS treatment, with a focus on oral antiplatelet therapies.

Acute Coronary Syndromes

TCT/AHA 2011: Antiplatelet Hot Topics

Dec 7, 2011 15:00 EST

ATLAS-ACS 2, BRIDGE, RAPID GENE, and TRACER are among the trials that Dr. Bhatt interviews Drs. Bonello, Mega, Kastrati, and Kleiman about.

Acute Coronary Syndromes

The Perfect Match: The Appropriate Antiplatelet Strategy for Patients Undergoing Primary PCI

Dec 7, 2011 09:20 EST

Dr. Bates outlines the management of 2 patients from presentation to follow-up including discussion of the 2011 updated PCI guidelines.

Acute Coronary Syndromes

PCI Guidelines 2011: Focus on Antiplatelet Therapies

2 COMMENTS - Nov 30, 2011 16:00 EST

Updated guidelines on use of antiplatelet agents in ACS. Drs. Bates, James, Montelescot, and Storey discuss the winners and losers.

Acute Coronary Syndromes

Balancing CV and GI Risk: Expert Perspectives

1 COMMENT - Nov 29, 2011 16:00 EST

Aspirin increases bleeding; rates are higher with dual therapy. But stopping antiplatelets increases cardiovascular events. Drs. Mehran and Scheiman discuss how to strike the right balance.

Acute Coronary Syndromes

ACS Clinical Trials and Registries Using Antiplatelet Agents: Where Does the Truth Lie?

1 COMMENT - Nov 23, 2011 10:03 EST

Clinical trials and registries. Do we need both? Drs. Lopes and Peterson discuss how to interpret and apply the data in clinical practice.

Acute Coronary Syndromes

Switching Antiplatelet Therapies: Case-Based Guidance on the Use of Platelet Testing

Nov 22, 2011 14:43 EST

Hitting the sweet spot for antiplatelet efficacy. Is platelet reactivity the answer? Drs. Lopes and Becker explore the possibilities.

Acute Coronary Syndromes

Antiplatelets in ACS: Expanding Choices

Oct 21, 2011 16:00 EDT

With the recent approval of a third P2Y₁₂ inhibitor, how should new agents be integrated into practice? Dr. Storey leads a case-based discussion with Drs. Geisler, Mehta, and Wiviott.

Interventional/Surgery

Stable Ischemic Heart Disease: Navigating the Decision to Intervene

Oct 3, 2011 13:44 EDT

When is it appropriate to revascularize patients with stable ischemic heart disease? Dr. King walks through 2 typical cases outlining the data behind his decision-making.

Acute Coronary Syndromes

NSTEMI Guidelines: Are the US and Europe in Harmony?

Sep 29, 2011 11:00 EDT

Dr. White asks Drs. Ohman and Fox about the similarities and differences between the 2 sets of guidelines.

Acute Coronary Syndromes

Antiplatelet Therapy in the Elderly Patient With ACS

Sep 14, 2011 10:50 EDT

Dr. Adam Skolnick reviews the data on how to manage elderly patients with ACS, focusing on antiplatelet and antithrombotic strategies.

Acute Coronary Syndromes

Antiplatelet Strategies in Acute Coronary Syndrome

Aug 30, 2011 14:18 EDT

Antiplatelet options in ACS are expanding across the globe. Dr. Abizaid from Brazil and Dr. Gaxiola from Mexico discuss 2 ACS cases and the data behind their decision-making.

Acute Coronary Syndromes

Acute Coronary Syndrome: Options for Primary and Secondary Prevention

1 COMMENT - Jun 23, 2011 16:00 EDT

Review the pathobiology of ACS, explore the updated guidelines for assessing and managing these patients, and discuss novel pharmacotherapies and issues surrounding platelet function and genetic testing.

Acute Coronary Syndromes

Antiplatelet Therapy for Atherothrombotic Disease: Unmasking the Data

Jun 23, 2011 12:17 EDT

Discuss the efficacy and safety of prescribing antiplatelet agents in patients with atherothrombotic disease.

Acute Coronary Syndromes

Antiplatelet Resistance: Does It Matter?

3 COMMENTS - Jun 22, 2011 15:32 EDT

GRAVITAS and the early cessation of TRIGGER-PCI left many wondering if testing antiplatelet response is worth it. Drs. ten Berg and Collet discuss the practical application of all the data.

Acute Coronary Syndromes

Defining the Future of Oral Anticoagulant Therapy: Across the Spectrum of Thromboembolic Disease

May 25, 2011 10:38 EDT

Drs. Becker and Weitz lead a discussion with Drs. Agnelli, Ezekowitz, Heit, and Mahaffey on the envisioned improvements in care of patients with thromboembolic disease

Acute Coronary Syndromes

Antiplatelet Therapy in ACS Patients With Prior Stroke

1 COMMENT - May 12, 2011 12:30 EDT

Dr. Wiviott leads a discussion with Dr. Mahaffey and neurologist Dr. Alberts on fine tuning therapy in this high-risk cohort.

Acute Coronary Syndromes

Pathway to Consensus: Reducing the GI Risk of Antiplatelet Therapy

May 9, 2011 10:13 EDT

Cardiologist Dr. Bhatt and gastroenterologist Dr. Scheiman discuss how to minimize the gastrointestinal risks of chronic antiplatelet therapy.

Acute Coronary Syndromes

PPIs, Platelets, and Outcomes: A Data Drill Down

1 COMMENT - May 4, 2011 14:25 EDT

Dr. Ohman leads a panel discussion with Drs. Gurbel and Steg that delves into the data and determines the practical implications.

Acute Coronary Syndromes

Antiplatelet Therapy in the ACS Patient Undergoing CABG

Apr 28, 2011 10:26 EDT

Surgeon Dr. Puskas and interventionalist Dr. Fox discuss bridging strategies and thienopyridine discontinuation as well as the ACC late-breaking STICH and RAPS trials.

Acute Coronary Syndromes

15th Annual Duke ACS Symposium

Apr 7, 2011 13:26 EDT

Review the atherothrombotic process, address the unmet needs of secondary prevention, and discuss approaches aimed at reducing residual risk in coronary heart disease to better manage patients with acute coronary syndromes.

Acute Coronary Syndromes

Management of Patients Following Acute Coronary Syndrome: A Key to Their Hearts Educational Activity

Mar 29, 2011 13:40 EDT

Using a case-based approach, review the role of the primary care clinician in improving medication compliance and risk factors in patients after ACS

Acute Coronary Syndromes

Individualized Antiplatelet Therapy in Practice

Mar 21, 2011 11:38 EDT

Dr. Mahmud explains the role of platelet function and genomic testing in tailoring oral antiplatelet therapy.

Acute Coronary Syndromes

Dispelling Myths and Discussing Unresolved Issues in Transradial vs Transfemoral Access in PCI

11 COMMENTS - Oct 18, 2010 10:46 EDT

Join Drs. Rao, Popma, Kandzari, and Kern as they discuss barriers to developing a radial-first strategy.